ALPL and atherosclerosis: TNAP and its substrates modulate a series of chronic inflammatory conditions, including aging-related degenerative diseases, such as atherosclerosis and Alzheimer’s disease, but also metabolic conditions, like insulin resistance and type 2 diabetes, occurring in the wake of chronic inflammation.